Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ekso Bionics Inc.

    NASDAQ: EKSO · Real-Time Price · USD
    3.83
    -0.04 (-0.91%)
    At close: Jun 13, 2025, 3:59 PM
    3.76
    -1.84%
    After-hours: Jun 13, 2025, 05:18 PM EDT

    Ekso Bionics Statistics

    Share Statistics

    Ekso Bionics has 2.4M shares outstanding. The number of shares has increased by 1.81% in one year.

    Shares Outstanding

    n/a
    		 2.4M

    Shares Change (YoY)

    n/a
    		 1.81%

    Shares Change (QoQ)

    n/a
    		 -0.1%

    Owned by Institutions (%)

    n/a
    		 19.89%

    Shares Floating

    n/a
    		 2.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 471

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 1.15M, so 48.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.15M

    Short % of Shares Out

    n/a
    		 48.65%

    Short % of Float

    n/a
    		 49.61%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.09 and the forward PE ratio is -1.1. Ekso Bionics's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.09

    Forward PE

    n/a
    		 -1.1

    PS Ratio

    n/a
    		 0.69

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0.97

    P/FCF Ratio

    n/a
    		 -1.24

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ekso Bionics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.5, with a Debt / Equity ratio of 0.47.

    Current Ratio

    n/a
    		 2.5

    Quick Ratio

    n/a
    		 1.89

    Debt / Equity

    n/a
    		 0.47

    Debt / EBITDA

    n/a
    		 -0.63

    Debt / FCF

    n/a
    		 -0.61

    Interest Coverage

    n/a
    		 -38.88

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $293,852.46

    Profits Per Employee

    n/a
    		 $-185,737.7

    Employee Count

    n/a
    		 61

    Asset Turnover

    n/a
    		 0.67

    Inventory Turnover

    n/a
    		 1.84

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -75.91% in the last 52 weeks. The beta is 0.89, so Ekso Bionics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.89

    52-Week Price Change

    n/a
    		 -75.91%

    50-Day Moving Average

    n/a
    		 5.58

    200-Day Moving Average

    n/a
    		 10

    Relative Strength Index (RSI)

    n/a
    		 30.04

    Average Volume (20 Days)

    n/a
    		 148,544

    Income Statement

    In the last 12 months, Ekso Bionics had revenue of 17.93M and earned -11.33M in profits. Earnings per share was -0.56.

    Revenue

    n/a
    		 17.93M

    Gross Profit

    n/a
    		 9.51M

    Operating Income

    n/a
    		 -10.46M

    Net Income

    n/a
    		 -11.33M

    EBITDA

    n/a
    		 -9.45M

    EBIT

    n/a
    		 -11.06M

    Earnings Per Share (EPS)

    n/a
    		 -0.56
    Full Income Statement

    Balance Sheet

    The company has 6.49M in cash and 5.98M in debt, giving a net cash position of 510K.

    Cash & Cash Equivalents

    n/a
    		 6.49M

    Total Debt

    n/a
    		 5.98M

    Net Cash

    n/a
    		 510K

    Retained Earnings

    n/a
    		 -250.47M

    Total Assets

    n/a
    		 27.31M

    Working Capital

    n/a
    		 11.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.85M and capital expenditures 0, giving a free cash flow of -9.88M.

    Operating Cash Flow

    n/a
    		 -9.85M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -9.88M

    FCF Per Share

    n/a
    		 -0.49
    Full Cash Flow Statement

    Margins

    Gross margin is 53.06%, with operating and profit margins of -58.35% and -63.21%.

    Gross Margin

    n/a
    		 53.06%

    Operating Margin

    n/a
    		 -58.35%

    Pretax Margin

    n/a
    		 -63.21%

    Profit Margin

    n/a
    		 -63.21%

    EBITDA Margin

    n/a
    		 -52.74%

    EBIT Margin

    n/a
    		 -58.35%

    FCF Margin

    n/a
    		 -55.14%

    Dividends & Yields

    EKSO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EKSO is $37.5, which is 879.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $37.5

    Price Target Difference

    n/a
    		 879.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 2, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 2, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -12.7

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist